HIV evolution: CTL escape mutation and reversion after transmission

Nature Medicine

Volumn 10, Issue 3, 2004, Pages 282-289

  Leslie, A J ^a   Pfafferott, K J ^a   Chetty, P ^b   Draenert, R ^c   Addo, M M ^c   Feeney, M ^c   Tang, Y ^c   Holmes, E C ^a   Allen, T ^c   Prado, J G ^d   Altfeld, M ^c   Brander, C ^c   Dixon, C ^a   Ramduth, D ^b   Jeena, P ^b   Thomas, S A ^b   St John, A ^e   Roach, T A ^e   Kupfer, B ^f   Luzzi, G ^g   Edwards, A ^h   Taylor, G ⁱ   Lyall, H ⁱ   Tudor Williams, G ⁱ   Novelli, V ^j   Martinez Picado, J ^d   Kiepiela, P ^b   Walker, B D ^c   Goulder, P J R ^a,c   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Queen Elizabeth II Hospital   (Barbados)

^f UNIVERSITY OF BONN   (Germany)

^g WYCOMBE HOSPITAL   (United Kingdom)

^h RADCLIFFE INFIRMARY   (United Kingdom)

ⁱ ST MARY S HOSPITAL   (United Kingdom)

^j GREAT ORMOND STREET HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN; HLA B57 ANTIGEN; HLA B5801 ANTIGEN; UNCLASSIFIED DRUG; HLA B ANTIGEN; HLA-B57;

ANTIGEN RECOGNITION; ARTICLE; CLADISTICS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPIDEMIC; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSURVEILLANCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; REVERTANT; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE; ADULT; AMINO ACID SEQUENCE; CHILD; DISEASE TRANSMISSION; FEMALE; GENETIC SELECTION; GENETIC VARIABILITY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MOLECULAR EVOLUTION; MUTATION; PHYLOGENY; PHYSIOLOGY; STATISTICAL MODEL; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

ADULT; AMINO ACID SEQUENCE; CHILD; DISEASE TRANSMISSION, VERTICAL; EPITOPES; EVOLUTION, MOLECULAR; FEMALE; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; LIKELIHOOD FUNCTIONS; MUTATION; PHYLOGENY; SELECTION (GENETICS); T-LYMPHOCYTES, CYTOTOXIC; VARIATION (GENETICS); VIRAL LOAD;

EID: 1842741699     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm992     Document Type: Article

References (45)

1. Koenig, S. et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1, 330-336 (1995).
2. Borrow, P. et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3, 205-211 (1997).
3. Goulder, P.J. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3, 212-217 (1997).
4. Barouch, D.H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335-339 (2002).
5. Klenerman, P., Wu, Y. & Phillips, R. HIV: current opinion in escapology. Curr. Opin. Microbiol. 5, 408-413 (2002).
6. Evans, D.T. et al. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5, 1270-1276 (1999).
7. Allen, T.M. et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407, 386-390 (2000).
8. Phillips, R.E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459 (1991).
9. Moore, C.B. et al. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296, 1439-1443 (2002).
10. Goulder, P.J. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334-338 (2001).
11. Kaslow, R.A. et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2, 405-411 (1996).
12. Migueles, S.A. et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. USA 97, 2709-2714 (2000).
13. O'Brien, S.J., Gao, X. & Carrington, M. HLA and AIDS: a cautionary tale. Trends Mol. Med. 7, 379-381 (2001).
14. Goulder, P.J. et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses 12, 1691-1698 (1996).
15. Tang, J. et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J. Virol. 76, 8276-8284 (2002).
16. + T-cell responses following acute HIV-1 infection. J. Virol. 76, 8690-8701 (2002).
17. Novitsky, V. et al. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J. Virol. 76, 10155-10168 (2002).
18. Addo, M.M. et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77, 2081-2092 (2003).
19. Altfeld, M.E.A. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17, 2581-2591 (2003).
20. Yang, Z. Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A. J. Mol. Evol. 51, 423-432 (2000).
21. McMichael, A. & Klenerman, P. HIV/AIDS. HLA leaves its footprints on HIV. Science 296, 1410-1411 (2002).
22. Frahm, N. et al. Identification of highly immunodominant regions in HIV by comprehensive CTL screening of ethnically diverse populations. J. Virol. (in the press).
23. Barber, L.D. et al. Polymorphism in the α1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J. Immunol. 158, 1660-1669 (1997).
24. Kelleher, A.D. et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193, 375-386 (2001).
25. Richman, D.D., Wrin, T., Little, S.J. & Petropoulos, C.J. Rapid evolution of the neutralizing antibody response to HIV type I infection. Proc. Natl. Acad. Sci. USA 100, 4144-4149 (2003).
26. Cohen, J. HIV. Escape artist par excellence. Science 299, 1505-1508 (2003).
27. + long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77, 6889-6898 (2003).
28. Coffin, J.M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489 (1995).
29. Greene, W.C. & Peterlin, B.M. Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy. Nat. Med. 8, 673-680 (2002).
30. Novitsky, V. et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J. Virol. 76, 5435-5451 (2002).
31. Singh, A.R., Hill, R.L. & Lingappa, J.R. Effect of mutations in Gag on assembly of immature human immunodeficiency virus type 1 capsids in a cell-free system. Virology 279, 257-270 (2001).
32. Furuta, R.A. et al. HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases. FEBS Lett. 415, 231-234 (1997).
33. Krogstad, P. et al. Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants. Virology 294, 282-288 (2002).
34. Forshey, B.M., von Schwedler, U., Sundquist, W.I. & Aiken, C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76, 5667-5677 (2002).
35. Braaten, D., Franke, E.K. & Luban, J. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group 0 HIV-1 or other primate immunodeficiency viruses. J. Virol. 70, 4220-4227 (1996).
36. Braaten, D., Franke, E.K. & Luban, J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70, 3551-3560 (1996).
37. Yoo, S. et al. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269, 780-795 (1997).
38. Goulder, P.J. et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193, 181-194 (2001).
39. Bunce, M. et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46, 355-367 (1995).
40. Goulder, P.J. et al. Rapid definition of five novel HLA-A* 3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by Elispot and intracellular cytokine staining assays. J. Virol. 75, 1339-1347 (2001).
41. Ross, H.A. & Rodrigo, A.G. Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J. Virol. 76, 11715-11720 (2002).
42. Yang, Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13, 555-556 (1997).
43. th edn. (Sinauer Associates, Sunderland, Massachusetts, 2002).
44. Hayman, A. et al. Phylogenetic analysis of multiple heterosexual transmission events involving subtype B of HIV type 1. AIDS Res. Hum. Retroviruses 17, 689-695 (2001).
45. Kasper, P. et al. The genetic diversification of the HIV type 1 gag p17 gene in patients infected from a common source. AIDS Res. Hum. Retroviruses 11, 1197-1201 (1995).